{
  "image_filename": "figure_p5_det_4_002.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/figure_p5_det_4_002.png",
  "image_type": "Figure",
  "page_number": 5,
  "block_id": "det_4_002",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "Kaplan-Meier plots of cumulative incidence of culture-positive CDC-defined influenza-like illness (ILI) for influenza A and influenza B, comparing placebo recipients (solid line) versus Flublok recipients (dashed line), with incidence counts and vaccine efficacy percentages noted beneath the plots. does not support the claim because the figure only presents data comparing Flublok to placebo, with no mention or inclusion of Fluarix as a comparator, so it doesn't support the claim that Flublok was evaluated against Fluarix. Note: Image appears clear; no indication or mention of Fluarix or any standard-dose vaccine comparator is visible.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Kaplan-Meier plots of cumulative incidence of culture-positive CDC-defined influenza-like illness (ILI) for influenza A and influenza B, comparing placebo recipients (solid line) versus Flublok recipients (dashed line), with incidence counts and vaccine efficacy percentages noted beneath the plots.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the figure only presents data comparing Flublok to placebo, with no mention or inclusion of Fluarix as a comparator, so it doesn't support the claim that Flublok was evaluated against Fluarix.",
    "confidence_notes": "Image appears clear; no indication or mention of Fluarix or any standard-dose vaccine comparator is visible."
  }
}